Approvals/CIMA-AEMPS/BORTEZOMIB AUROVITAS 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG

Approved

STANDARD

BORTEZOMIB AUROVITAS 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG

Eugia Pharma (Malta) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 1171f6db37a15545
Drug Cima Aemps Name: BORTEZOMIB AUROVITAS 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG
Register Number: 85623
Holder Company Name: Eugia Pharma (Malta) Limited
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2020-12-01
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 3.5 mg
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Eugia Pharma (Malta) Limited

BORTEZOMIB

3,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 1, 2020

Approval ID

1171f6db37a15545

Type

Standard